A novel and functional interaction between cyclophilin A and prolactin receptor
- PMID: 12668872
- DOI: 10.1385/ENDO:20:1-2:83
A novel and functional interaction between cyclophilin A and prolactin receptor
Abstract
Precedent data have revealed that peptidyl isomerases can modulate the function of cell-surface receptors, but no such interactions have been previously shown for the members of the cytokine receptor superfamily. We demonstrate here that a functional interaction occurs between the prolactin receptor (PRLR) and peptidyl prolyl cis/trans isomerase cyclophilin A (CypA). CypA was co-immunoprecipitated with the PRLR in vivo from the breast epithelial cell line T47D and Chinese hamster ovary transfectants overexpressing transfected human PRLR. In addition, in vitro binding assays demonstrated a direct interaction of CypA with the PRLR, in the presence or absence of cyclosporine. Co-immunoprecipitation studies also showed an association of CypA with Jak2. Functional analysis revealed that overexpression of CypA inhibited PRL-induced Rac activation, while simultaneously prolonging Jak2 phosphorylation. These proximal actions had profound downstream effects: CypA overexpression significantly enhanced the basal and PRL-stimulated expression from a beta-casein reporter construct. Hence, the interaction between CypA and the PRLR plays a differential regulatory role in the various signaling pathways leading from the PRLR.
Similar articles
-
Characterization of a novel and functional human prolactin receptor isoform (deltaS1PRLr) containing only one extracellular fibronectin-like domain.Mol Endocrinol. 2002 Oct;16(10):2310-22. doi: 10.1210/me.2001-0033. Mol Endocrinol. 2002. PMID: 12351696
-
N-glycosylation of the prolactin receptor is not required for activation of gene transcription but is crucial for its cell surface targeting.Mol Endocrinol. 1998 Apr;12(4):544-55. doi: 10.1210/mend.12.4.0085. Mol Endocrinol. 1998. PMID: 9544990
-
Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor.Endocrinology. 2001 Dec;142(12):5286-93. doi: 10.1210/endo.142.12.8549. Endocrinology. 2001. PMID: 11713228
-
New mechanisms for PRLr action in breast cancer.Trends Endocrinol Metab. 2009 Jul;20(5):223-9. doi: 10.1016/j.tem.2009.03.001. Epub 2009 Jun 15. Trends Endocrinol Metab. 2009. PMID: 19535262 Review.
-
Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.Endocr Rev. 1998 Jun;19(3):225-68. doi: 10.1210/edrv.19.3.0334. Endocr Rev. 1998. PMID: 9626554 Review.
Cited by
-
Molecular aspects of cyclophilins mediating therapeutic actions of their ligands.Cell Mol Life Sci. 2010 Oct;67(20):3467-88. doi: 10.1007/s00018-010-0437-0. Epub 2010 Jul 4. Cell Mol Life Sci. 2010. PMID: 20602248 Free PMC article. Review.
-
Cyclophilin A Function in Mammary Epithelium Impacts Jak2/Stat5 Signaling, Morphogenesis, Differentiation, and Tumorigenesis in the Mammary Gland.Cancer Res. 2018 Jul 15;78(14):3877-3887. doi: 10.1158/0008-5472.CAN-17-2892. Epub 2018 Jun 29. Cancer Res. 2018. PMID: 29959151 Free PMC article.
-
Isoform-specific inhibition of cyclophilins.Biochemistry. 2009 Jul 7;48(26):6268-77. doi: 10.1021/bi9007287. Biochemistry. 2009. PMID: 19480458 Free PMC article.
-
Orchestration of signaling by structural disorder in class 1 cytokine receptors.Cell Commun Signal. 2020 Aug 24;18(1):132. doi: 10.1186/s12964-020-00626-6. Cell Commun Signal. 2020. PMID: 32831102 Free PMC article.
-
Extracellular cyclophilin-A stimulates ERK1/2 phosphorylation in a cell-dependent manner but broadly stimulates nuclear factor kappa B.Cancer Cell Int. 2012 Jul 4;12(1):19. doi: 10.1186/1475-2867-12-19. Cancer Cell Int. 2012. PMID: 22631225 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous